HomeCompareHRPMF vs O

HRPMF vs O: Dividend Comparison 2026

HRPMF yields 56.98% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HRPMF wins by $527.0K in total portfolio value
10 years
HRPMF
HRPMF
● Live price
56.98%
Share price
$3.51
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$561.2K
Annual income
$126,052.94
Full HRPMF calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.15
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,102.74
Full O calculator →

Portfolio growth — HRPMF vs O

📍 HRPMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHRPMFO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HRPMF + O cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HRPMF pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HRPMF
Annual income on $10K today (after 15% tax)
$4,843.30/yr
After 10yr DRIP, annual income (after tax)
$107,145.00/yr
O
Annual income on $10K today (after 15% tax)
$449.12/yr
After 10yr DRIP, annual income (after tax)
$4,337.33/yr
At 15% tax rate, HRPMF beats the other by $102,807.67/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HRPMF + O for your $10,000?

HRPMF: 50%O: 50%
100% O50/50100% HRPMF
Portfolio after 10yr
$297.7K
Annual income
$65,577.84/yr
Blended yield
22.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

HRPMF
No analyst data
Altman Z
-40.5
Piotroski
2/9
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.7% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HRPMF buys
0
O buys
0
No recent congressional trades found for HRPMF or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHRPMFO
Forward yield56.98%5.28%
Annual dividend / share$2.00$3.23
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.1%
Portfolio after 10y$561.2K$34.2K
Annual income after 10y$126,052.94$5,102.74
Total dividends collected$460.7K$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: HRPMF vs O ($10,000, DRIP)

YearHRPMF PortfolioHRPMF Income/yrO PortfolioO Income/yrGap
1← crossover$16,398$5,698.01$10,818$608.16+$5.6KHRPMF
2$26,278$8,732.33$11,787$741.68+$14.5KHRPMF
3$41,196$13,078.29$12,946$911.00+$28.3KHRPMF
4$63,241$19,161.35$14,345$1,127.94+$48.9KHRPMF
5$95,159$27,490.76$16,056$1,409.05+$79.1KHRPMF
6$140,479$38,659.15$18,171$1,777.83+$122.3KHRPMF
7$203,650$53,337.34$20,820$2,268.21+$182.8KHRPMF
8$290,169$72,263.73$24,188$2,929.90+$266.0KHRPMF
9$406,709$96,228.48$28,533$3,837.11+$378.2KHRPMF
10$561,232$126,052.94$34,235$5,102.74+$527.0KHRPMF

HRPMF vs O: Complete Analysis 2026

HRPMFStock

Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying CDNF-based therapies for Parkinson's disease (PD). Its lead product in pipeline includes HER-096, an advanced small and synthetic chemical peptidomimetic version of the active parent as the preclinical xCDNF candidate for the treatment of PD and other neurodegenerative diseases; and recombinant human Cerebral Dopamine Neurotrophic Factor (rhCDNF), a biological protein that is in Phase I study in patients with PD. The company was incorporated in 2008 and is based in Espoo, Finland.

Full HRPMF Calculator →

OREIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this HRPMF vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HRPMF vs SCHDHRPMF vs JEPIHRPMF vs KOHRPMF vs MAINHRPMF vs STAGHRPMF vs ADCHRPMF vs NNNHRPMF vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.